Literature DB >> 25319043

Cognitive and psychological functioning in Fabry disease.

Linda Sigmundsdottir1, Michel C Tchan2, Alex A Knopman3, Graham C Menzies3, Jennifer Batchelor4, David O Sillence2.   

Abstract

Fabry disease is an X-linked lysosomal storage disorder which can result in renal, cardiac, and cerebrovascular disease. Patients are at increased risk of stroke and neuroimaging studies note cerebrovascular pathology. This study provides a cognitive profile of a cohort of individuals with Fabry disease and investigates the impact of pain, age, renal, cardiac, and cerebrovascular functioning on cognition and psychological functioning. Seventeen Fabry patients (12 males) with ages ranging 25 to 60 years (M = 46.6+11.8), and 15 age-matched healthy controls (M = 46.2+12.7) were administered a comprehensive neuropsychological battery. Fabry males demonstrated slower speed of information processing, reduced performance on measures of executive functions (verbal generation, reasoning, problem solving, perseveration), were more likely to show clinically significant reductions, and were more likely to report symptoms of anxiety and depression. Conversely, Fabry females performed at a similar level to controls. Correlational analyses indicated a link between cognitive and clinical measures of disease severity.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Anxiety; Cognition; Depression; Fabry disease; Neuropsychology; Psychology

Mesh:

Year:  2014        PMID: 25319043      PMCID: PMC4263929          DOI: 10.1093/arclin/acu047

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  31 in total

1.  White matter lesion severity in male and female patients with Fabry disease.

Authors:  A Fellgiebel; M J Müller; M Mazanek; K Baron; M Beck; P Stoeter
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years.

Authors:  T N Tombaugh; A M Hubley
Journal:  J Clin Exp Neuropsychol       Date:  1997-12       Impact factor: 2.475

3.  The vascular dementia of Fabry's disease.

Authors:  M F Mendez; T M Stanley; N M Medel; Z Li; D T Tedesco
Journal:  Dement Geriatr Cogn Disord       Date:  1997 Jul-Aug       Impact factor: 2.959

4.  Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Authors:  Perri Segal; Yoav Kohn; Yehuda Pollak; Gheona Altarescu; Esti Galili-Weisstub; Annick Raas-Rothschild
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

Review 5.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

6.  An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia.

Authors:  Riki Okeda; Masahiro Nisihara
Journal:  Neuropathology       Date:  2008-04-11       Impact factor: 1.906

Review 7.  The cerebral vasculopathy of Fabry disease.

Authors:  David F Moore; Christine R Kaneski; Hasan Askari; Raphael Schiffmann
Journal:  J Neurol Sci       Date:  2007-03-23       Impact factor: 3.181

8.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

9.  The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Authors:  C Whybra; C Kampmann; F Krummenauer; M Ries; E Mengel; E Miebach; F Baehner; K Kim; M Bajbouj; A Schwarting; A Gal; M Beck
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Neurology of Fabry disease.

Authors:  M Low; K Nicholls; N Tubridy; P Hand; D Velakoulis; L Kiers; P Mitchell; G Becker
Journal:  Intern Med J       Date:  2007-07       Impact factor: 2.048

View more
  9 in total

1.  Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Authors:  Josefine Loeb; Ulla Feldt-Rasmussen; Christoffer Valdorff Madsen; Asmus Vogel
Journal:  JIMD Rep       Date:  2018-04-14

2.  Treatment of Depression in Adults with Fabry Disease.

Authors:  Nadia Ali; Scott Gillespie; Dawn Laney
Journal:  JIMD Rep       Date:  2017-04-18

Review 3.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

4.  Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease.

Authors:  Lukas Hofmann; Franziska Karl; Claudia Sommer; Nurcan Üçeyler
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Leonardo Vedolin; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

6.  Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Leonardo Vedolin; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  Orphanet J Rare Dis       Date:  2020-01-28       Impact factor: 4.123

7.  Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review.

Authors:  Magdalena Mroczek; Ignazio Maniscalco; Manon Sendel; Ralf Baron; Erich Seifritz; Albina Nowak
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

8.  Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.

Authors:  Kai K Kummer; Theodora Kalpachidou; Miodrag Mitrić; Michiel Langeslag; Michaela Kress
Journal:  Front Mol Neurosci       Date:  2018-06-25       Impact factor: 5.639

9.  Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients.

Authors:  Amy Kritzer; Aishwarya Siddharth; Kate Leestma; Olaf Bodamer
Journal:  Mol Genet Metab Rep       Date:  2019-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.